Ad
related to: moderna
Search results
Moderna and Novavax Hope for Early Launch of This Year’s Covid-19 Shots, Despite FDA Delay
Barrons.com· 5 hours agoVaccine makers Moderna and Novavax are hoping for an August rollout this year, earlier than last...
Moderna wins a battle in vaccine patent dispute with Pfizer-BioNTech - The Boston Globe
The Boston Globe· 3 days agoModerna said Friday that the European Patent Office has upheld the validity of one of its key...
Dow Jones Dips As AI Stock Microsoft Shines; Nvidia Rallies On These Bullish Calls
Investor's Business Daily· 3 hours agoTechnology was a top performer in the composite, rallying 3% after Morgan Stanley upgraded the stock...
European Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech
Benzinga· 3 days agoModerna Inc MRNA has reportedly achieved a significant victory at the European Patent Office (EPO)...
Moderna wins COVID shot patent case against Pfizer-BioNTech in Europe
Reuters via AOL· 3 days agoThe company has been locked in a legal battle with Pfizer-BioNTech over their COVID shot Comirnaty...
Moderna Inc (MRNA)'s Uncertain Future: Understanding the Barrier
Guru Focus· 7 hours agoLong-established in the Biotechnology industry, Moderna Inc (MRNA, Financial) has enjoyed a stellar reputation. Notably, its diminished rankings in financial strength, growth ...
Does AI Really Make Moderna Stock (NASDAQ:MRNA) a Buy?
TipRanks via Yahoo Finance· 3 days agoModerna (NASDAQ:MRNA) stock has collapsed from its all-time high. However, the company is once again...
Moderna Stock Rebounds From Its RSV Vaccine Fallout — Is It A Buy, Again?
Investor's Business Daily· 6 days agoModerna stock tumbled — and then rebounded — after the Food and Drug Administration delayed its RSV...
Could Novavax Become the Next Moderna?
Motley Fool via Yahoo Finance· 4 days agoNovavax (NASDAQ: NVAX) and Moderna (NASDAQ: MRNA) both entered the coronavirus vaccine race around the same time, in early pandemic days, and their...
Is This a Setback for Moderna?
The Motley Fool via AOL· 7 days agoInvestors have put their hopes in Moderna's (NASDAQ: MRNA) next potential product, a respiratory syncytial virus (RSV) vaccine. That's because it...
